Association of Meibomian Gland Dysfunction with Oral Statin Useopen access
- Authors
- Park, Sun-Kyoung; Lee, Ji-Hye; Hwang, Ho-Sik; Kim, Hyun-Seung; Han, Kyung-Do; Na, Kyung-Sun
- Issue Date
- Aug-2022
- Publisher
- MDPI
- Keywords
- meibomian gland dysfunction; dry eye disease; statin; HMG-CoA reductase inhibitor; meiboscore
- Citation
- JOURNAL OF CLINICAL MEDICINE, v.11, no.15
- Journal Title
- JOURNAL OF CLINICAL MEDICINE
- Volume
- 11
- Number
- 15
- URI
- http://scholarworks.bwise.kr/ssu/handle/2018.sw.ssu/43548
- DOI
- 10.3390/jcm11154632
- ISSN
- 2077-0383
- Abstract
- This retrospective cross-sectional study aimed to determine the association of oral statin use, dry eye disease (DED), and meibomian gland dysfunction (MGD). A total of 93 subjects were included and divided into two groups: statin users (n = 45) and nonstatin users (n = 47). Significant differences were observed in the total cholesterol (p = 0.013), low-density lipoprotein (LDL) (p = 0.005), and meiboscore (p = 0.000) levels between the two groups. For stratified analysis, the statin group was divided into subgroups according to the type or dose of statin and total duration of statin use. However, there were no differences in clinical features between the subgroups. In multiple regression analysis, meiboscore was significantly associated with age (slope = 0.05, p = 0.00) and statin use (slope = -1.19, p = 0.00), with an R-2 of 0.44. Thus, older adults and participants who do not use statin appeared to have higher scores. In conclusion, although the mechanism is unclear, statins may exert a protective effect on the meibomian gland. Further lipidomic studies are required to determine the pharmacological effects of statins on the meibomian gland and other meibum components.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - ETC > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.